Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
HCP Jobs
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
Edition
European
US
Oncology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Helicobacter Pylori Treatment Could Minimise Gastric Cancer Risk
1
Mins
July 2024
Researchers have unveiled that Helicobacter pylori treatment may be beneficial for individuals with a high genetic risk to gastric cancer.
Read more
1
Mins
16th August 2016
Introducing EMJ Reproductive Health 2.1
United Kingdom, August 16, 2016: Welcome to this year’s EMJ Reproductive Health, a journal exploring the latest insights and important developments from…
2
Mins
22nd July 2016
ESMO 2018 Annual Congress to be held in Munich
Switzerland, 21 July, 2016 – ESMO, the leading European professional organisation for medical oncology, has announced that the ESMO 2018 Annual Congress…
2
Mins
12th July 2016
Introducing EMJ Neurology 4.1
Welcome to EMJ Neurology 4.1, an edition filled with informative and engaging content which spotlights the latest research and developments in the field…
3
Mins
5th July 2016
Anti-Interleukin-1 Alpha Antibody MABp1 Improves Outcomes Significantly over Placebo
Barcelona-Lugano, July 02, 2016 – A novel anti-interleukin 1-alpha antibody has shown a significant impact on symptoms, and a high level of safety and…
4
Mins
30th June 2016
Regorafenib Shows Significant Survival Gains in Refractory Liver Cancer
Barcelona-Lugano, June 30, 2016 – Oral multikinase inhibitor regorafenib achieves significantly improved survival rates compared to placebo in patients…
4
Mins
29th June 2016
Anti-PD-L1 Immunotherapy Shows Response in Microsatellite-Stable Metastatic Colorectal Cancer in Combination with MEK Inhibition
June 29, 2016 – Anti-PD-L1 immunotherapy may achieve a response in patients with microsatellite-stable metastatic colorectal cancer if combined with…
7
Mins
13th June 2016
Daratumumab (DARZALEX®) Combination Therapy Significantly Extended Progression-Free Survival in Previously Treated Patients with Multiple Myeloma
Beerse, Belgium, 5 June 2016 – Data from the Phase 3 MMY3004 (CASTOR) clinical trial show the immunotherapy daratumumab (DARZALEX®) in combination with a…
2
Mins
13th June 2016
Helsinn Group Hosts a Satellite Symposium on Shared Decision Making in Supportive Care, at the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) Annual Meeting 2016 on June 24th
Lugano, Switzerland, June 13, 2016 – Helsinn, the Swiss pharmaceutical Group focused on building quality cancer care, today announces that it is…
Loading posts...
« Previous
1
…
24
25
26
27
28
…
32
Next »